Here's Why Constellation Brands Is Cozying Up to Cannabis

Here's Why Constellation Brands Is Cozying Up to Cannabis

Beer, wine, and spirits Goliath Constellation Brands (NYSE: STZ) surprised everyone with news last week that it's acquiring a nearly 10% stake in marijuana stock Canopy Growth (NASDAQOTH: TWMJF) for 245 million Canadian dollars. The investment positions Constellation Brands as a leader in suds and buds. Should you consider making this investment too?

In this episode of The Motley Fool's Industry Focus: Healthcare, analyst Kristine Harjes is joined by Todd Campbell to explain why Constellation is so interested in marijuana and what could be on tap next for shareholders. Also in this episode, the two reveal why CVS Health (NYSE: CVS) is eyeing Aetna (NYSE: AET), and how EXACT Sciences (NASDAQ: EXAS) is improving the odds of avoiding colon cancer -- the second most deadly cancer in the United States.

A full transcript follows the video.

Continue reading

Source: Fool.com